Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
24.14
-0.45 (-1.83%)
Jun 5, 2026, 12:51 PM EDT - Market open
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $2.63 billion as of June 5, 2026. Its market cap has increased by 397.12% in one year.
Market Cap
2.63B
Enterprise Value
2.35B
1-Year Change
397.12%
Ranking
Category
Stock Price
$24.14
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $2.63B, an increase of 342.23%. That is a compound annual growth rate of 26.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 2.57B | 95.06% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 2.85B |
| Structure Therapeutics | 2.64B |
| Arcutis Biotherapeutics | 2.60B |
| Disc Medicine | 2.60B |
| Alumis | 2.55B |
| Tarsus Pharmaceuticals | 2.47B |
| IDEAYA Biosciences | 2.45B |
| Mineralys Therapeutics | 2.38B |